Hemispherx Biopharma (HEB) Reports Q1 Loss of $0.01
Tweet
Share
E-mailGet Alerts HEB Hot Sheet
Price: $1.80 --0%
Financial Fact:
Research and development: 900K
Today's EPS Names:
ZTO, AMMX, AFIB, More
Financial Fact:
Research and development: 900K
Today's EPS Names:
ZTO, AMMX, AFIB, More
Join SI Premium – FREE
Hemispherx Biopharma (NYSE: HEB) reported Q1 EPS of ($0.01), versus ($0.02) reported last year.
For earnings history and earnings-related data on Hemispherx Biopharma (HEB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TJX stock drops as profit outlook falls short of analyst estimates
- Marti Technologies (MRT) Misses Q2 EPS by 9c ; Offers Guidance
- Viking Holdings Ltd (VIK) Tops Q2 EPS by 36c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
